Biocon Biologics India Limited, a fully integrated ‘pure play’ biosimilars company, a subsidiary of Biocon Ltd., is pleased to announce that, Shreehas Tambe, its Chief Operating Officer, has been conferred the UAA-ICT Distinguished Alumnus Award (Professional) 2020 for his contribution to the field of biopharmaceuticals.
Founded in 1933, Institute of Chemical Technology (ICT), Mumbai is recognized among the top schools in the world and counts several greats from academia and industry amongst its alumni. The Distinguished Alumnus Awards were instituted in 1990 to recognize outstanding contribution of its alumni in their respective fields and professions. Some of the past recipients of this coveted award have been ‘Padma’ awardees like Prof. MM Sharma, Prof. JB Joshi, Dr. RA Mashelkar and Industry Icons such as Mr. Mukesh Ambani (Reliance), Dr. Anji Reddy (DRL), Mr. Kishore Mariwala (Marico) to list a few. Mr Shreehas Tambe an alumnus of ICT, Mumbai, graduated from the prestigious institute in 1997.
Commenting on his achievement, Mr Shreehas Tambe, COO, Biocon Biologics said: “I am deeply humbled and privileged to receive this coveted award from my alma mater and join past recipients whom I have admired and respected for long. The UAA-ICT Distinguished Alumnus Award (Professional) 2020, is a recognition of our commitment at Biocon to make innovation affordable and healthcare solutions accessible to patients globally – a vision that resonates perfectly with ICT as well.
The confluence of physical sciences along with mathematics holds great promise to solving some of the biggest challenges facing the world today. ICT, Mumbai continues to play a pivotal role in imparting knowledge, pushing the boundaries of science and engineering and shaping the leaders of tomorrow making a huge contribution to industry and academia. I am extremely proud to be associated with this prestigious institution”
Mr. Shreehas Tambe began his professional journey at Biocon Ltd as a management trainee in 1997 starting out in the R&D department, where he led the design and development of a novel bioreactor that later became Biocon’s first U.S. patent to be granted and won the National Award for Best Technology of the Year in 2001.
He also set up the immunosuppressants franchise bringing innovative automation approaches to address challenging fermentation and complex chemistry problems. He along with his colleagues has authored several patents on these immunosuppressants. Under his leadership, Biocon made its first overseas investment in research and manufacturing infrastructure, building one of the largest integrated Insulins complex in Asia which is approved by FDA and EMA among other global regulatory agencies.
Mr. Shreehas Tambe has held several leadership positions in operations, capital investment projects and business strategy during his tenure of over 20 years in Biocon. Before he became President and Chief Operating Officer and a member of the Executive Leadership Team at Biocon Biologics in 2018, he was Senior Vice President & Global Head of Biocon’s insulins business unit. He was responsible for the P&L and managed the development of the Insulins portfolio expanding its reach to various geographies. Currently, he is also the Chair and a key member of internal committees looking at governance, investments and strategic collaborations.
The UDCT Alumni Association (UAA) is the interactive networking and information platform for all alumni of ICT, Mumbai. The institute is devoted towards education, training, research and industrial collaboration in chemical engineering, chemical technology, applied chemistry, pharmacy, biotechnology and bio-processing.